Key result
A female in her sixties developed stress (takotsubo) cardiomyopathy as a rare cardiovascular manifestation of COVID-19, presenting with acute left ventricular dysfunction and apical ballooning.
Why the study?
Stress (takotsubo) cardiomyopathy is rarely seen in patients with COVID-19.
Case Report (n=1)
Highlights stress (takotsubo) cardiomyopathy as a rare cardiovascular manifestation of COVID-19.
May warrant consideration of takotsubo in COVID-19 with LV dysfunction; single case leaves open prevalence and causality.
Patients with coronavirus disease 2019 (COVID-19) may present with a broad spectrum of clinical manifestations, affecting several organ systems. Predominant cardiac manifestations include myocardial injury, heart failure, cardiogenic shock, and arrhythmias. Stress (takotsubo) cardiomyopathy, characterized by apical ballooning of the heart leading to acute left ventricular dysfunction, is rarely seen in patients with COVID-19. We present a case of COVID-19-associated stress cardiomyopathy in a female in her sixties.
No takes yet. Share an insight, caveat, or question.
Abdullah et al. (2023) conducted a case report in COVID-19-associated stress cardiomyopathy (n=1). COVID-19 was evaluated. A female in her sixties developed stress (takotsubo) cardiomyopathy as a rare cardiovascular manifestation of COVID-19, presenting with acute left ventricular dysfunction and apical ballooning.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: